Vitrolife AB (publ) (OTCMKTS:VTRLY – Get Free Report) was upgraded by research analysts at Handelsbanken from a “market perform” rating to an “outperform” rating in a research report issued on Friday, FlyOnTheWall reports.
Vitrolife AB (publ) Price Performance
About Vitrolife AB (publ)
Vitrolife AB (publ) engages in development, production, and marketing of products for assisted reproduction. It provides oocyte retrieval needles; sperm processing; in vitro fertilization media and oil; micromanipulation pipettes; labware; incubators; cryopreservation; and preimplantation genetic testing products.
Further Reading
- Five stocks we like better than Vitrolife AB (publ)
- Stock Average Calculator
- China’s Jump In Car Sales Is Drawing Big Money To These Stocks
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- 3 Reasons Price Weakness Is a Buying Opportunity For Lennar
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Name A Better Trio Than These Underrated High Potential Stocks
Receive News & Ratings for Vitrolife AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitrolife AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
